The majority of Robin’s 25+ years in the profession has been spent handling contentious matters in the biotech and pharmaceutical sectors.
His current practice focusses on EP oppositions and appeals and supporting pan-European litigation.
Robin is based in our Munich office and heads the firm’s Opposition and UPC practice group. A British/German national, Robin started his career in 2001 with Reddie & Grose in London before moving to Germany in 2006 to work in-house for one of the world’s leading pharmaceutical companies. In his final role in-house, he was the global head of the small molecules patent team.
Since returning to private practice, Robin’s work reflects his in-house experiences and focuses on commercial and contentious matters including oppositions; due diligence; licencing and launch & litigation strategies in European and non-European jurisdictions. Throughout his career Robin has supported numerous pharmaceutical & biologic product launches that required navigating complex patent landscapes.
Robin also advises his pharmaceutical and biotech clients on the interplay between regulatory and patent derived exclusivities and helps devise strategies relating to supplementary protection certificates and patent term extensions.
Complimenting his pharmaceutical background, Robin has a wealth of experience working with medical devices, supporting clients in technologies ranging from inhalers to cranial perforators.
Robin enjoys snowboarding and surfing and despite living in the shadow of Bayern Munich, is an avid Norwich City fan.
